SCHEMBL6410904

SCHEMBL6410904

O=C1OC(CN2CCC(Cc3cc(F)ccc3Cl)CC2)CN1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 4/20 0.43
ALDH1A1 P00352 2/20 0.43
HTR1A P08908 4/20 0.43
SLC6A4 P31645 1/20 0.43
SIGMAR1 Q99720 4/20 0.42
CCR3 P51677 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GRM2 Q14416 2/20 0.38
HTR2A P28223 1/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6411591 0.90 ALDH1A1 (0.45) ATMALDH1A1HTR1ASLC6A4SIGMAR1
SCHEMBL6410119 0.90 ATM (0.43) ATMHTR1ASLC6A4SIGMAR1CCR3
SCHEMBL6417310 0.88 CCR3 (0.37) HTR1ASLC6A4SIGMAR1CCR3HTR2A
SCHEMBL6409952 0.87 ATM (0.43) ATMALDH1A1HTR1ASLC6A4SIGMAR1
SCHEMBL6411962 0.86 HTR1A (0.61) HTR1ASLC6A4SIGMAR1MEN1KMT2A
SCHEMBL6410338 0.86 GRM2 (0.47) SIGMAR1GRM2
SCHEMBL6414466 0.86 SLC6A4 (0.37) HTR1ASLC6A4SIGMAR1CCR3L3MBTL1
SCHEMBL6418448 0.85 HTR1A (0.50) ATMALDH1A1HTR1ASLC6A4SIGMAR1
SCHEMBL6411207 0.84 HTR1A (0.49) ATMALDH1A1HTR1ASLC6A4SIGMAR1
SCHEMBL6410666 0.82 ATM (0.44) ATMALDH1A1HTR1ASLC6A4SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065140-A1 Serotonine reuptake inhibitor SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2005-03-24 US disclosed
EP-1466901-A1 SEROTONINE REUPTAKE INHIBITOR SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065140-A1 Serotonine reuptake inhibitor HTR1A, SLC6A4, SLC6A2 ATM 4128/4885ALDH1A1 828/4885HTR1A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.